Balancing Act: How Do Investors Weigh Founders Versus Markets in Medtech and Healthtech Venture? July 25, 2024
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services June 27, 2024
Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform April 9, 2024
Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024 April 8, 2024
ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma October 24, 2023
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test September 25, 2023